Conference Description:

Your Dedicated Forum for Opening the Doors to New Enzyme-Enabled Chemistries for Process Ready and Scalable Synthesis

In 2023, an era of advanced protein engineering technology is rapidly creating new opportunities for the generation of game-changing enzymes for novel transformations.

With renewed excitement in their application for faster, cheaper and sustainable means of small molecule and API production without the need for precious metal catalysts, biocatalysis is fast being prioritized as biopharma's synthesis route of choice.

Join industry titans in Biocatalysis, Enzyme Engineering, MedChem and Process Chemistry uniting at the 3rd Applied Biocatalysis Summit this December, to accelerate enzyme discovery and engineering, discover carbon footprint-reducing reactions and refine their process scaling strategies.

Across 3 days, engage in hours of networking and hear from the industry's most passionate minds, including Merck, Amgen, Sanofi, Pfizer, and many more provide a complete roadmap for fast-tracking novel transformations towards GMP.

This is a must attend event for those who are looking to expand their catalytic toolbox for greener chemistries!


URLs:
Tickets: https://go.evvnt.com/1898810-2?pid=154Sponsor: https://go.evvnt.com/1898810-4?pid=154
Time: 10:00 AM - 3:30 PM

Prices:
Drug Developer | Conference Only: USD 2099.00,
Academic and NFP | Conference Only: USD 1699.00

Speakers: Adrian Ortiz, Director of Process Development, Amgen, Anne Mohan, Senior Chemical Engineer, Merck, Jason Tedrow, Global Head of Process Chemistry, Sanofi, Jovan Livada, Senior Scientist, Pfizer, Erin O'Brien, Executive Director, Head of Small Molecule Development, Biogen, Ryan Phelan, Principal Scientist, AbbVie, Phillip Clayman, Investigator, Biocatalysis Chemistry, GlaxoSmithKline, Brenden Derstine, Senior Scientist, Chemical Development, Neurocrine Biosciences